What is the recommended starting dose of Buspar (buspirone) for a patient already taking 15mg of Lexapro (escitalopram)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 26, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Starting Dose of Buspirone for a Patient on 15mg Lexapro

Start buspirone at 7.5 mg twice daily (15 mg total daily dose) and increase by 5 mg per day every 2-3 days as needed, up to a maximum of 60 mg daily. 1

Initial Dosing Strategy

  • The FDA-approved starting dose is 15 mg daily, administered as 7.5 mg twice daily. 1
  • The dose may be increased by 5 mg per day at intervals of 2-3 days to achieve optimal therapeutic response. 1
  • Most patients in clinical trials were successfully managed on divided doses of 20-30 mg per day. 1, 2
  • The maximum daily dose should not exceed 60 mg per day. 3, 1

Critical Timing and Administration Considerations

  • Buspirone must be taken consistently with regard to food—either always with food or always without food—because food increases bioavailability approximately 2-fold. 1, 4
  • The medication requires 2-4 weeks to become effective for anxiety symptoms, so patients should be counseled about delayed onset of action. 3
  • When combining with escitalopram (Lexapro), there are no specific dose adjustments required for buspirone, as no significant pharmacokinetic interactions exist between SSRIs and buspirone. 1

Drug Interaction Screening

  • Verify the patient is not taking MAOIs—at least 14 days must elapse between discontinuing an MAOI and starting buspirone, and vice versa. 1
  • Screen for potent CYP3A4 inhibitors (verapamil, diltiazem, erythromycin, itraconazole), which can substantially increase buspirone plasma concentrations and may require dose reduction. 1, 4
  • Rifampin decreases buspirone concentrations nearly 10-fold, potentially requiring dose increases if co-administered. 4

Practical Dosing Algorithm

Week 1:

  • Start 7.5 mg twice daily (morning and evening). 1

Week 1-2 (Days 3-7):

  • If tolerated but insufficient response, increase to 10 mg twice daily (20 mg total). 1

Week 2-3:

  • If needed, increase to 15 mg twice daily (30 mg total)—this is the most commonly employed dose in clinical trials. 1, 2

Beyond Week 3:

  • Continue titrating by 5 mg per day every 2-3 days up to maximum 60 mg daily if clinically indicated. 1

Safety Considerations with Escitalopram Combination

  • The combination of buspirone and SSRIs like escitalopram is well-established and commonly used for augmentation in treatment-resistant depression or anxiety. 5
  • Buspirone augmentation of SSRIs has been shown to reduce depression severity more effectively than other augmentation strategies in some studies. 5
  • Monitor for serotonin syndrome symptoms, though the risk is low with this combination at standard doses. 1
  • Both medications are generally well-tolerated together without significant additive side effects. 6, 7

Common Pitfalls to Avoid

  • Do not discontinue buspirone prematurely before 2-4 weeks of adequate dosing—patients may abandon therapy before therapeutic effects emerge. 3
  • Avoid inconsistent administration with respect to food, as this creates variable plasma concentrations and unpredictable efficacy. 1, 4
  • Do not exceed 60 mg daily, as higher doses have not been studied and may increase adverse effects without additional benefit. 3, 1
  • Remember that buspirone lacks the immediate anxiolytic effects of benzodiazepines and requires patient education about delayed onset. 3, 6

Monitoring Parameters

  • Assess therapeutic response at 2-4 weeks after reaching target dose. 3
  • Monitor for common side effects including dizziness, headache, nausea, and lightheadedness. 6, 7
  • The incidence of adverse events is generally low, and buspirone has no abuse potential or withdrawal syndrome. 6, 2

References

Guideline

Maximum Daily Dose of Buspirone

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Bupropion Dosing and Administration

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.